Insights
Trending Now
Bitcoin’s February selloff reflects orderly deleveraging rather than capitulation. Despite a roughly 20% YTD decline, leverage has normalized and volatility remains below prior bear-market levels.
AI is quietly reshaping drug discovery, improving early-stage efficiency and influencing how biotech innovators and pharmaceutical leaders approach pipeline development and long-term growth.
Trending Funds
_ of _